Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophreniform; Schizophrenic”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableStudy completedNCT00399334
What this trial is testing

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Janssen-Cilag, S.A. 1,607
Not applicableStudy completedNCT00174200
What this trial is testing

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer 20
Post-approval studies (Phase 4)Study completedNCT00333177
What this trial is testing

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 92
Large-scale testing (Phase 3)Study completedNCT00159770
What this trial is testing

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290
Post-approval studies (Phase 4)Ended earlyNCT00681629
What this trial is testing

Schizophrenic Patients in Integrated Care

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
AstraZeneca 7
Post-approval studies (Phase 4)Study completedNCT00485823
What this trial is testing

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Who this might be right for
Schizophrenic Disorders
Eli Lilly and Company 48
Testing effectiveness (Phase 2)Ended earlyNCT00734435
What this trial is testing

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Orexigen Therapeutics, Inc 26
Early research (Phase 1)Looking for participantsNCT05025605
What this trial is testing

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Who this might be right for
SchizophreniaSchizo-Affective DisorderSchizophreniform; Schizophrenic+2 more
BioXcel Therapeutics Inc 140
Testing effectiveness (Phase 2)Study completedNCT01354132
What this trial is testing

N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis

Who this might be right for
Schizophrenic Psychoses
Beth Israel Deaconess Medical Center 20
Post-approval studies (Phase 4)Study completedNCT06041646
What this trial is testing

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar DisorderSchizophreniaAgitation,Psychomotor+2 more
BioXcel Therapeutics Inc 29